Literature DB >> 2889282

Optimal discrimination of mild hyperparathyroidism with total serum calcium, ionized calcium and parathyroid hormone measurements.

L Benson1, S Ljunghall, T Groth, H Falk, A Hvarfner, J Rastad, L Wide, G Akerström.   

Abstract

The serum concentrations of calcium, albumin and parathyroid hormone (PTH) and the plasma levels of ionized calcium were determined in 124 healthy subjects, 89 patients with primary hyperparathyroidism (HPT), 23 of whom had the syndrome of multiple endocrine neoplasia type 1 (MEN-1) and 43 patients who had hypercalcaemia of other causes than HPT (non-HPT), in most cases due to widespread malignancies. The total serum calcium was corrected for the serum albumin concentration (CaM). Healthy females over the age of 50 had higher CaM, than younger females and the women of all ages also had, higher serum PTH levels than males. For all study groups both the intra- and inter-diurnal variations were small for all the studied variables. Discriminant function and optimal discriminatory limits were calculated with the help of computer programs. A consideration of all the individuals in the discriminant analysis, revealed that measurements of CaM alone separated most HPT patients both from the healthy subjects and from the non-HPT patients. However, when only those who had borderline values (defined as CaM between 2.45 and 2.75 mmol/l) were included it turned out that measurements of ionized calcium markedly improved the delineation of mild HPT from the healthy subjects and that, in addition, PTH measurements helped to exclude those with non-HPT hypercalcaemia. The optimal discriminatory levels of serum calcium were calculated as the levels which caused the minimum loss in terms of misclassification when attention was paid to the relative importance of false positive to false negative classifications and to the prevalence of HPT. The optimal discriminatory level for serum calcium for a weighting ratio between false positive to false negative of 1:1, and a prevalence of HPT of 1%, was calculated to be 2.68 mmol/l and for a prevalence of 50% 2.56 mmol/l. In the latter situation a weighting ratio of 10:1 for false positive to false negative gave a level of 2.63 mmol/l while a weighting ratio of 1:10 corresponded to an optimal discriminatory level of 2.47 mmol/l.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889282     DOI: 10.3109/03009738709178686

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  5 in total

1.  Improvement in histological diagnosis of primary hyperparathyroidism with a monoclonal antiparathyroid antibody.

Authors:  Gunnel Bjerneroth; Claes Juhlin; Lars Grimelius; Jonas Rastad; Göran Åkerström
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

2.  Improved differential diagnosis of hypercalcemia by hypocalcemic stimulation of parathyroid hormone secretion.

Authors:  S Ljunghall; L Benson; L Wide; G Akerström; J Rastad
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

3.  Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.

Authors:  S Ljunghall; P Hellman; J Rastad; G Akerström
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

4.  Dynamics of parathyroid hormone release and serum calcium regulation after surgery for primary hyperparathyroidism.

Authors:  W Graf; J Rastad; G Akerström; L Wide; S Ljunghall
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

5.  Ultrasonographic evaluation of parathyroid hyperplasia in multiple endocrine neoplasia type 1: Positive correlation between parathyroid volume and circulating parathyroid hormone concentration.

Authors:  Hiroyuki Tamiya; Megumi Miyakawa; Akira Takeshita; Daishu Miura; Yasuhiro Takeuchi
Journal:  J Bone Miner Metab       Date:  2014-09-17       Impact factor: 2.626

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.